StreamSolutions
StreamSolutions Raises $25M Series A to Transform Biotech
Quick Facts
StreamSolutions Raises $25M Series A in Latest Funding Round
StreamSolutions has successfully closed a $25M Series A funding round, marking a significant milestone in the company's growth trajectory. The round was led by Khosla Ventures, with participation from Coatue.
Company Overview
Founded in 2020 and headquartered in Washington, DC, StreamSolutions has established itself in the Biotech space. Leading AI-powered analytics platform transforming data into actionable business insights
With a current valuation of $150M, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $25M Series A
- Valuation: $150M
- Lead Investor: Khosla Ventures
Future Outlook
As StreamSolutions moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza